Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.053 | 0.7 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |